| Human Health and Disease | Lifetime | 4 | RU 3 | 99.58 |
| Healthcare Systems and Public Health | Lifetime | 9 | RU 8 | 99.22 |
| COVID-19 and healthcare impacts | Lifetime | 549 | RU 1 | 94.25 |
| Cardiovascular Disease and Adiposity | Lifetime | 889 | RU 3 | 95.92 |
| Biomarkers in Disease Mechanisms | Lifetime | 171 | RU 3 | 93.98 |
| Cardiovascular Health and Risk Factors | Lifetime | 452 | RU 4 | 94.50 |
| Cardiac Health and Mental Health | Lifetime | 920 | RU 6 | 94.77 |
| Global Public Health Policies and Epidemiology | Lifetime | 649 | RU 2 | 93.80 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 900 | RU 41 | 92.65 |
| Nutrition, Genetics, and Disease | Lifetime | 893 | RU 3 | 91.80 |
| Medical Coding and Health Information | Lifetime | 239 | RU 1 | 86.30 |
| Medical and Pharmaceutic Studies | Lifetime | 25 | RU 1 | 86.17 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 761 | RU 1 | 87.42 |
| Medical and Agricultural Research Studies | Lifetime | 48 | RU 29 | 86.44 |
| Technology and Human Factors in Education and Health | Lifetime | 345 | RU 200 | 83.00 |
| GDF15 and Related Biomarkers | Lifetime | 637 | RU 5 | 79.41 |
| Social and Behavioral Studies | Lifetime | 374 | RU 241 | 73.98 |
| Intramuscular injections and effects | Lifetime | 631 | RU 6 | 69.35 |
| Sex and Gender in Healthcare | Lifetime | 925 | RU 2 | 68.37 |
| Law, AI, and Intellectual Property | Lifetime | 557 | RU 23 | 67.87 |
| Digital Transformation in Law | Lifetime | 692 | RU 455 | 59.18 |
| Healthcare Systems and Public Health | 2021-2025 | 1 | RU 1 | 99.60 |
| Human Health and Disease | 2021-2025 | 1 | RU 1 | 99.91 |
| Cardiac Health and Mental Health | 2021-2025 | 16 | RU 1 | 98.40 |
| Neuroprotection in Stroke and Neurodegeneration | 2021-2025 | 10 | RU 2 | 96.36 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 32 | RU 1 | 97.68 |
| Biomarkers in Disease Mechanisms | 2021-2025 | 6 | RU 1 | 95.54 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 37 | RU 1 | 97.44 |
| COVID-19 and healthcare impacts | 2021-2025 | 195 | RU 1 | 96.09 |
| Nutrition, Genetics, and Disease | 2021-2025 | 31 | RU 1 | 95.77 |
| Chronic Disease Management Strategies | 2021-2025 | 139 | RU 1 | 95.44 |
| Heart Rate Variability and Autonomic Control | 2021-2025 | 209 | RU 1 | 94.96 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 227 | RU 2 | 96.08 |
| Acute Myocardial Infarction Research | 2021-2025 | 267 | RU 5 | 96.45 |
| Cardiac, Anesthesia and Surgical Outcomes | 2021-2025 | 557 | RU 3 | 95.33 |
| Global Public Health Policies and Epidemiology | 2021-2025 | 127 | RU 1 | 92.90 |
| Diet, Metabolism, and Disease | 2021-2025 | 191 | RU 1 | 94.44 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 251 | RU 3 | 94.90 |
| Obesity, Physical Activity, Diet | 2021-2025 | 554 | RU 1 | 94.87 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 716 | RU 1 | 95.42 |
| Diet and metabolism studies | 2021-2025 | 703 | RU 1 | 93.96 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 229 | RU 1 | 92.61 |
| Heart Failure Treatment and Management | 2021-2025 | 399 | RU 3 | 95.14 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 818 | RU 4 | 94.98 |
| Nutritional Studies and Diet | 2021-2025 | 549 | RU 1 | 93.97 |
| Obesity and Health Practices | 2021-2025 | 163 | RU 1 | 90.07 |
| Mobile Health and mHealth Applications | 2021-2025 | 417 | RU 2 | 90.19 |
| Thermoregulation and physiological responses | 2021-2025 | 215 | RU 4 | 90.53 |
| Health, psychology, and well-being | 2021-2025 | 170 | RU 1 | 85.44 |
| Medical and Agricultural Research Studies | 2021-2025 | 10 | RU 9 | 88.51 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 587 | RU 2 | 89.05 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 85 | RU 1 | 84.47 |
| Body Composition Measurement Techniques | 2021-2025 | 289 | RU 1 | 88.10 |
| Gout, Hyperuricemia, Uric Acid | 2021-2025 | 205 | RU 2 | 86.09 |
| Medication Adherence and Compliance | 2021-2025 | 372 | RU 3 | 82.35 |
| Smoking Behavior and Cessation | 2021-2025 | 586 | RU 1 | 86.26 |
| Infrared Thermography in Medicine | 2021-2025 | 306 | RU 11 | 79.40 |
| Pericarditis and Cardiac Tamponade | 2021-2025 | 182 | RU 6 | 76.56 |
| Alcohol Consumption and Health Effects | 2021-2025 | 700 | RU 1 | 80.03 |
| Sex and Gender in Healthcare | 2021-2025 | 132 | RU 1 | 80.15 |
| Health Literacy and Information Accessibility | 2021-2025 | 476 | RU 2 | 77.40 |
| Social and Behavioral Studies | 2021-2025 | 101 | RU 74 | 76.15 |
| Health and Medical Research Impacts | 2021-2025 | 431 | RU 3 | 74.22 |
| Medical and Biological Sciences | 2021-2025 | 313 | RU 91 | 72.67 |
| Technology and Human Factors in Education and Health | 2021-2025 | 182 | RU 124 | 73.28 |
| Healthcare cost, quality, practices | 2021-2025 | 849 | RU 1 | 71.22 |
| Sodium Intake and Health | 2021-2025 | 484 | RU 9 | 72.12 |
| Economic and Technological Developments in Russia | 2021-2025 | 873 | RU 726 | 74.23 |
| Cardiovascular Syncope and Autonomic Disorders | 2021-2025 | 721 | RU 1 | 69.50 |
| Autopsy Techniques and Outcomes | 2021-2025 | 345 | RU 6 | 68.55 |
| Apelin-related biomedical research | 2021-2025 | 211 | RU 3 | 67.30 |
| Clinical practice guidelines implementation | 2021-2025 | 987 | RU 3 | 64.81 |
| Public Health Policies and Education | 2021-2025 | 482 | RU 1 | 58.84 |
| Intramuscular injections and effects | 2021-2025 | 196 | RU 5 | 56.80 |
| Case Reports on Hematomas | 2021-2025 | 243 | RU 4 | 53.42 |
| Biomedical and Engineering Education | 2021-2025 | 994 | RU 4 | 51.91 |
| Medical Coding and Health Information | 2021-2025 | 385 | RU 6 | 24.96 |
